Suppr超能文献

头孢地尔对来自沙特阿拉伯的临床上重要的碳青霉烯类不敏感革兰氏阴性菌的体外活性。

In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia.

作者信息

Alzayer Maha, Alghoribi Majed F, Alalwan Bassam, Alreheli Abdualah, Aljohani Sameera, Bosaeed Mohammad, Doumith Michel

机构信息

Infectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

出版信息

J Glob Antimicrob Resist. 2023 Mar;32:176-180. doi: 10.1016/j.jgar.2022.11.013. Epub 2022 Dec 5.

Abstract

OBJECTIVES

Cefiderocol is a novel catechol-substituted siderophore cephalosporin with broad-spectrum activity against Gram-negative pathogens. However, variation of its activity among carbapenemase producers from various regions and countries has been reported. Here, we checked the in vitro activity against Gram-negative carbapenem non-susceptible bacteria collected in Saudi Arabia.

METHODS

Cefiderocol MICs were determined using the iron-depleted cation-adjusted Mueller-Hinton broth and interpreted according to the Clinical and Laboratory Standards Institute guidelines. Isolates (n = 288) included carbapenemase-producing Escherichia coli (n = 46), Klebsiella pneumoniae (n = 98), Acinetobacter baumannii (n = 65), and Pseudomonas aeruginosa (n = 79) clinical isolates.

RESULTS

Cefiderocol inhibited 73.26% (211/288) of the isolates studied at concentrations of ≤ 4 mg/L. Cefiderocol inhibited all carbapenem-resistant A. baumannii isolates (65/65, 100%) producing OXA-23-like, OXA-24-like, and NDM, and nearly all P. aeruginosa isolates (75/79, 94.94%), including those producing VIM and NDM. In contrast, the carbapenemase-producing isolates from the Enterobacterales group demonstrated significantly higher MICs with only 53.06% (52/98) of K. pneumoniae and 41.3% (19/46) of E. coli isolates exhibiting MICs of ≤4 mg/L. Isolates showing elevated MICs (73/144, 50.69%) included NDM (20/29, 68.97%), NDM/OXA-48-like (34/59, 57.63%), OXA-48-like (18/52, 34.62%), and KPC (1/4, 25%) producers, thus showing no clear association with the production of serine-type or metallo-type carbapenemases. However, high cefiderocol MICs (≥ 32mg/L) were associated with isolates producing NDM, and in particular, among those coproducing the OXA-232-type enzyme.

CONCLUSIONS

Cefiderocol had excellent activity against multi-drug resistant non-fermenting Gram-negative pathogens. Reasons behind the high cefiderocol MICs in certain Enterobacterales isolates need further investigation.

摘要

目的

头孢地尔是一种新型的儿茶酚取代的铁载体头孢菌素,对革兰氏阴性病原体具有广谱活性。然而,据报道,其活性在来自不同地区和国家的碳青霉烯酶产生菌中存在差异。在此,我们检测了其对在沙特阿拉伯收集的革兰氏阴性碳青霉烯不敏感细菌的体外活性。

方法

使用缺铁阳离子调整的 Mueller-Hinton 肉汤测定头孢地尔的 MIC,并根据临床和实验室标准协会指南进行解读。分离株(n = 288)包括产碳青霉烯酶的大肠埃希菌(n = 46)、肺炎克雷伯菌(n = 98)、鲍曼不动杆菌(n = 65)和铜绿假单胞菌(n = 79)临床分离株。

结果

头孢地尔在浓度≤4 mg/L 时抑制了 73.26%(211/288)的研究分离株。头孢地尔抑制了所有产碳青霉烯酶的鲍曼不动杆菌分离株(65/65,100%),这些分离株产生 OXA-23 样、OXA-24 样和 NDM,以及几乎所有铜绿假单胞菌分离株(75/79,94.94%),包括那些产生 VIM 和 NDM 的分离株。相比之下,肠杆菌科中产碳青霉烯酶的分离株显示出明显更高的 MIC,肺炎克雷伯菌分离株中只有 53.06%(52/98)和大肠埃希菌分离株中只有 41.3%(19/46)的 MIC≤4 mg/L。MIC 升高的分离株(73/144,50.69%)包括 NDM(20/29,68.97%)、NDM/OXA-48 样(34/59,57.63%)、OXA-48 样(18/52,34.62%)和 KPC(1/4,25%)产生菌,因此与丝氨酸型或金属型碳青霉烯酶的产生没有明显关联。然而,头孢地尔高 MIC(≥32mg/L)与产生 NDM 的分离株相关,特别是在那些同时产生 OXA-232 型酶的分离株中。

结论

头孢地尔对多重耐药的非发酵革兰氏阴性病原体具有优异的活性。某些肠杆菌科分离株中头孢地尔 MIC 高的原因需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验